Skip to content

Retardation of Myopia in Orthokeratology

Orthokeratology for Myopic Control in Chinese Children - a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00962208
Acronym
ROMIO
Enrollment
102
Registered
2009-08-19
Start date
2008-03-31
Completion date
2011-12-31
Last updated
2013-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

children, corneal reshaping, myopia, myopia control, orthokeratology

Brief summary

The primary aim of this study is to evaluate and compare the eyeball elongation in children wearing orthokeratology lenses and single-vision spectacles.

Detailed description

Prevalence of myopia is high in Asian countries like Hong Kong. Orthokeratology has shown potential in slowing myopic progression but the efficacy is yet to be confirmed by a randomized clinical trial (RCT). The current RCT aims at studying the efficacy of orthokeratology in retardation of myopic progression by comparing the eye growth in terms of axial length elongation in children wearing orthokeratology lenses (study group) and those wearing single-vision spectacles (control group).

Interventions

Nightly use of orthokeratology to correct the refractive error for a period of two years

Daily use of spectacles to correct the refractive error for a period of two years

Sponsors

Menicon Co., Ltd.
CollaboratorINDUSTRY
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
6 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* Myopia (refractive sphere): \> 0.50D and ≤ 4.00D * Astigmatism: \< ½ of myopia; with-the-rule astigmatism (axes 180 +/- 30) ≤1.25D; astigmatism of other axes ≤ 0.50D * Spherical equivalent (SE): \> 0.75D and ≤ 4.50D * Anisometropia: ≤ 1.50D in both refractive sphere, refractive cylinder and SE * Best corrected monocular visual acuity: equal to or better than 0.10 in logMAR scale in both eyes * Willingness for randomization * Willingness to wear contact lenses or spectacles on a daily basis * Availability for follow-up for at least 2 years

Exclusion criteria

* Strabismus at distance or near * Contraindication for contact lens wear and orthokeratology (e.g. limbus to limbus corneal cylinder and dislocated corneal apex * Prior experience with the use of rigid lenses (including orthokeratology) * Prior experience with myopia control treatment (e.g. refractive therapy or progressive add spectacles) * Systemic or ocular conditions which may affect contact lens wear (e.g. allergy and medication) * Systemic or ocular conditions which may affect refractive development (e.g. Down syndrome, ptosis)

Design outcomes

Primary

MeasureTime frameDescription
Axial Elongation in the Study and Control Subjects Who Completed the Two Years Study2 yearsAxial elongation was determined by the change in axial length of the eyeball before and after treatment period. Axial length was measured by the IOLMaster (Zeiss Humphrey, Dublin, CA) 30 minutes after cycloplegia. The measurement of the axial length followed the procedures as recommended by the manufacturer.

Secondary

MeasureTime frame
Determine the Incidence of Adverse Effects in Cornea, the Palpebral, Bulbar and Tarsal Conjunctiva in the Study and the Control Groups2 years
Determine Changes in Other Ocular Parameters (e.g. Corneal Biomechanics and Aberration) Associated With Orthokeratology Lens Wear2 years

Countries

China

Participant flow

Recruitment details

Phone screening was conducted on all parents who responded to advertisements in local newspapers during March 2008 and June 2009. Those who passed the screening would be invited to attend the baseline visit at the Optometry Clinic of The Hong Kong Polytechnic University.

Pre-assignment details

All subjects who passed the inclusion and exclusion criteria at the baseline visit would be assigend to the treatment according to the randomization log.

Participants by arm

ArmCount
Orthokeratology Lenses
Study group: children were asked to wear orthokeratology lenses every night (Menicon Z Night Lens: Menicon Z material, DK 163 ISO; central lens thickness: 0.24 mm) to correct the refractive error during the study period.
51
Single-vision Spectacle Lenses
Control group: children were asked to wear single-vision spectacles (CR-39 material with refractive index 1.56) in the daytime to correct the refractive error during the study period.
51
Total102

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyContraindicated to continue study51
Overall StudyCould not achieve good vision90
Overall StudyLost to Follow-up09

Baseline characteristics

CharacteristicSingle-vision Spectacle LensesOrthokeratology LensesTotal
Age, Categorical
<=18 years
51 Participants51 Participants102 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age Continuous9.27 years
STANDARD_DEVIATION 1.09
9.28 years
STANDARD_DEVIATION 1.1
9.28 years
STANDARD_DEVIATION 1.09
Region of Enrollment
China
51 participants51 participants102 participants
Sex: Female, Male
Female
25 Participants25 Participants50 Participants
Sex: Female, Male
Male
26 Participants26 Participants52 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 510 / 51
serious
Total, serious adverse events
0 / 510 / 51

Outcome results

Primary

Axial Elongation in the Study and Control Subjects Who Completed the Two Years Study

Axial elongation was determined by the change in axial length of the eyeball before and after treatment period. Axial length was measured by the IOLMaster (Zeiss Humphrey, Dublin, CA) 30 minutes after cycloplegia. The measurement of the axial length followed the procedures as recommended by the manufacturer.

Time frame: 2 years

ArmMeasureValue (MEAN)Dispersion
Orthokeratology LensesAxial Elongation in the Study and Control Subjects Who Completed the Two Years Study0.36 mmStandard Deviation 0.24
Single-vision Spectacle LensesAxial Elongation in the Study and Control Subjects Who Completed the Two Years Study0.63 mmStandard Deviation 0.26
Secondary

Determine Changes in Other Ocular Parameters (e.g. Corneal Biomechanics and Aberration) Associated With Orthokeratology Lens Wear

Time frame: 2 years

Secondary

Determine the Incidence of Adverse Effects in Cornea, the Palpebral, Bulbar and Tarsal Conjunctiva in the Study and the Control Groups

Time frame: 2 years

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026